» Articles » PMID: 1720593

Interferon Treatment Inhibits Early Events in Vaccinia Virus Gene Expression in Infected Mice

Overview
Journal Virology
Specialty Microbiology
Date 1991 Dec 1
PMID 1720593
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

We have analyzed the role of exogenous administration of mouse interferon (IFN alpha + beta) on the replication of vaccinia virus in peritoneal cells and in the spleen of Balb/c mice. Mice were pretreated for 16 hr with IFN and then infected with a vaccinia virus recombinant expressing luciferase under an early or late virus promoter, and the enzyme activity was measured in the course of virus infection. A dose of IFN as low as 10(3) units/mouse abolished the appearance of luciferase activity in cells of the peritoneal cavity and in spleen cells. The IFN-mediated inhibition of luciferase activity was observed even when mice were infected 4 days after the administration of IFN. The IFN-treated animals were considered free of virus since neither luciferase nor viral proteins were detected in target cells several days after virus infection. Despite a severe IFN-mediated inhibition of luciferase activity, the appearance of luciferase on mRNA levels was not inhibited 6 hr after virus infection. Our finding revealed that replication of vaccinia virus in Balb/c mice is exquisitively sensitive to inhibition by IFN and that this effect occurs at early times postinfection, most likely as a result of a translational block.

Citing Articles

Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism.

Pilna H, Hajkova V, Knitlova J, Liskova J, Elsterova J, Melkova Z Viruses. 2021; 13(10).

PMID: 34696416 PMC: 8539567. DOI: 10.3390/v13101986.


CD8+ T cell-derived IFN-γ prevents infection by a second heterologous virus.

Valentine L, Potts R, Premenko-Lanier M J Immunol. 2012; 189(12):5841-8.

PMID: 23136204 PMC: 3518669. DOI: 10.4049/jimmunol.1201679.


Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in mice.

Gomez C, Perdiguero B, Najera J, Sorzano C, Jimenez V, Gonzalez-Sanz R J Virol. 2012; 86(9):5026-38.

PMID: 22419805 PMC: 3347383. DOI: 10.1128/JVI.06684-11.


Glycosaminoglycans mediate retention of the poxvirus type I interferon binding protein at the cell surface to locally block interferon antiviral responses.

Montanuy I, Alejo A, Alcami A FASEB J. 2011; 25(6):1960-71.

PMID: 21372110 PMC: 3101028. DOI: 10.1096/fj.10-177188.


Role of PKR and Type I IFNs in viral control during primary and secondary infection.

Nakayama Y, Plisch E, Sullivan J, Thomas C, Czuprynski C, Williams B PLoS Pathog. 2010; 6(6):e1000966.

PMID: 20585572 PMC: 2891951. DOI: 10.1371/journal.ppat.1000966.